Delivery Order SPE2DB20D1100-SPE2DB24FC9W1

Award Date 7/29/24
Potential Completion Date 8/19/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $48,090.80, is for the supply of GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin product. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $71,915.80 delivery order is for the supply of GAMUNEX-C 40 gram/400 ML vials, a specialty medication. The order has an ultimate completion date of August 9, 2024. The primary IDC, valued at up to $999,999,999, enables the DLA to efficiently procure a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,530.00 contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a performance period through December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,022.70, is for the delivery of GAMUNEX-C, a 40 gram/400 ml vial of pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 23, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The $11,912.50 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $57,708.96 to AmerisourceBergen Drug Corp for the supply of 40-gram/400-mL vials of the pharmaceutical product GAMUNEX-C. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA and AmerisourceBergen for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The firm-fixed-price contract has a total ceiling value of $69,599.48 and a period of performance through October 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC9W1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GAMUNEX-C 10 gram/100 ml vial in the amount of $12,022.80. The order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation. The award has an ultimate completion date of August 19, 2024.

Generated 10/28/24, 9:52 AM